NXN — Nexsen Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$32.03m
- AU$32.04m
- AU$1.09m
Annual cashflow statement for Nexsen, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Changes in Working Capital | 0.042 | -0.044 | -3.21 | -3.34 |
| Change in Taxes Payable | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 0.042 | -0.044 | -3.21 | -3.34 |
| Capital Expenditures | -0.056 | -0.513 | -0.081 | -0.003 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Cash from Investing Activities | -0.056 | -0.513 | -0.081 | -0.003 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.005 | 1.13 | 3.12 | 7.41 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.01 | 0.578 | -0.168 | 4.07 |